Skip to content

Test Cartridge BC4

by Edan Instruments, Inc.

Test Cartridge BC4 is a Class II device made by Edan Instruments, Inc., cleared under FDA 510(k) K151978 on 15 Jul 2016 and listed in FDA GUDID since 1 Sep 2016 (UDI-DI 06944413802940), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K151978

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number06944413802940 UDI-DI Date1 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberK151978 Date15 Jul 2016IssuedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K151978 decided 15 Jul 2016 Active
  • FDA GUDID UDI-DI 06944413802940 listed 1 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K151978
  2. Listed FDA GUDID 06944413802940

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Test Cartridge
Generic name
Multiple blood gas analyte IVD, kit, ion-selective electrode (ISE)
Model / reference
BC4
Primary DI / UDI-DI
06944413802940
510(k) Number
FDA product code
CHL
GMDN term
Multiple blood gas analyte IVD, kit, ion-selective electrode (ISE)
Device class
Class II
Regulation number
862.1120
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code CHL (Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph).

Other devices from Edan Instruments, Inc.

See all devices from Edan Instruments, Inc. →

Properties

  • Single use
  • Prescription use
  • Lot / batch number
  • Serial number
  • Expiration date
  • Manufacturing date
Other properties (9, all answered No)